Drug Database
Back to search

Poland· PL-100156420

Celiprolol Vitabalans

A celiprolol product containing celiprololi hydrochloridum, registered in Poland by Vitabalans Oy. The same ATC class is registered in 10 of our 19 countries.

ATC C07AB08

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCeliprolol VitabalansATCC07AB08REGISTER NO.PL-100156420PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about celiprololi hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Celiprolol is registered in 10 of 19 countries.

Countries holding a registration under ATC C07AB08 (celiprolol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search celiprolol products by name

Celiprolol · ATC C07AB08

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of celiprolol costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.19 in France to $0.83 in Switzerland — a ×4.3 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Celiprolol · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.83
  • FR France$0.19
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Celiprololi hydrochloridum
Manufacturer
Vitabalans Oy
Country
Poland (PL)
ATC code
C07AB08
ATC class
Celiprolol
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909990865109
  • gtin
    05909990865123
  • gtin
    05909990865093

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

42 interactions on record for celiprolol.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check celiprolol against other medicinesHow interaction checks work

Celiprolol · interactions on record

42 records

42 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Celiprolol in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All celiprolol products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Czechia · Celiprolol Vitabalans, Tenoloc
  • Germany · Celipro Lich, Celitin
  • Finland · Celiprolol Vitabalans
  • France · Celectol, Celiprolol Almus
  • United Kingdom (Northern Ireland) · Celectol
  • Greece · Alopril, Zilovis
  • Hungary · Celiprolol Vitabalans
  • Italy · Cordiax
  • Netherlands · Celiprolol Hcl Teva
  • Slovakia · Celiprolol Vitabalans

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cf9a523b-b4a1-42ec-80c4-c277efe14fa9
GET /v1/drugs/cf9a523b-b4a1-42ec-80c4-c277efe14fa9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "400 mg",
  "packaging": "05909990865093 ¦ Rp ¦ 66230\n30 tabl.\n05909990865109 ¦ Rp ¦ 66231\n60 tabl.\n05909990865123 ¦ Rp ¦ 66232\n100 tabl.",
  "substance": "Celiprololi hydrochloridum 400 mg",
  "common_name": "Celiprololi hydrochloridum",
  "pl_product_id": "100156420",
  "pozwolenie_nr": "18225",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about celiprolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console